Acute myeloid leukemia with t(16;21)(q24;q22), CBFA2T3::RUNX1, in post-treatment setting, a case report

被引：0
作者：
Yang, T. [1 ]
Khan, A. I. [1 ]
Hanan, A. [1 ]
Kataria, N. [1 ]
Khan, A. [1 ]
机构：
[1] Northwell Hlth, Pathol, Great Neck, NY USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2023年 / 160卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [31] Prognosis and treatment outcome in patients with acute myeloid Leukemia with t(8;21)(q22;q22)
    Chih-Cheng Chen
    Jyh-Pyng Gau
    Yuan-Bin Yu
    Chang-Hsien Lu
    Kuan-Der Lee
    Jie-Yu You
    Advances in Therapy, 2007, 24 : 907 - 920
  • [32] Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22)
    Chen, Chih-Cheng
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Lu, Chang-Hsien
    Lee, Kuan-Der
    You, Jie-Yu
    ADVANCES IN THERAPY, 2007, 24 (04) : 907 - 920
  • [33] HETEROGENEITY OF ACUTE MYELOID LEUKEMIA WITH TRANSLOCATION T(8;21)(Q22;Q22)
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Zjuzgin, I. S.
    Karjagina, E. V.
    Martinenko, L. S.
    Petrova, E. V.
    Tsibakova, N. J.
    Ivanova, M. P.
    Kostroma, I. I.
    Abdulkadyrov, K. M.
    HAEMATOLOGICA, 2014, 99 : 570 - 570
  • [34] Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)
    Gritsaev, S. V.
    Martynkevich, I. S.
    Zyuzgin, I. S.
    Karyagina, E. V.
    Martynenko, L. S.
    Petrova, E. V.
    Tsybakova, N. Yu.
    Ivanova, M. P.
    Kostroma, I. I.
    Tiranova, S. A.
    Potikhonova, N. A.
    Abdulkadyrov, K. M.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (07) : 45 - 52
  • [35] Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia
    Asou, Norio
    Yanagida, Masatoshi
    Huang, Liqun
    Yamamoto, Masayuki
    Shigesada, Katsuya
    Mitsuya, Hiroaki
    Ito, Yoshiaki
    Osato, Motomi
    BLOOD, 2007, 109 (09) : 4023 - 4027
  • [36] Cisplatin/EtoposideAcute myeloid leukaemia with CBFA2T3::RUNX1
    Reactions Weekly, 2024, 2010 (1) : 110 - 110
  • [37] Identification of a Cryptic t(8;20;21)(q22;p13;q22) Resulting in RUNX1T1/RUNX1 Fusion in a Patient with Newly Diagnosed Acute Myeloid Leukemia
    Macke, Erica L.
    Meyer, Reid G.
    Hoppman, Nicole L.
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Xu, Xinjie
    Baughn, Linda B.
    Shafer, Danielle A.
    He, Rui R.
    Peterson, Jess F.
    LABORATORY MEDICINE, 2022, 53 (04) : E87 - E90
  • [38] t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia
    Ishida, F
    Ueno, M
    Tanaka, H
    Makishima, H
    Suzawa, K
    Hosaka, S
    Hidaka, E
    Ishikawa, M
    Yamauchi, K
    Kitano, K
    Kiyosawa, K
    CANCER GENETICS AND CYTOGENETICS, 2002, 132 (02) : 133 - 135
  • [39] A Novel and Cytogenetically Cryptic t(7;21)(q36.1;q22) Disrupting <bold>RUNX1</bold> in Acute Myeloid Leukemia
    Zamecnikova, Adriana
    Al Bahar, Soad
    CYTOGENETIC AND GENOME RESEARCH, 2018, 156 (03) : 140 - 143
  • [40] Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/RUNX1::RUNX1T1: Selecting Optimal Treatment Based on Clinical and Molecular Findings
    Fernandez-Sanchez, Adolfo
    Hernandez-Sanchez, Alberto
    De Ramon, Cristina
    Chillon, Maria-Carmen
    Vidriales, Maria Belen
    Baile-Gonzalez, Monica
    Fuentes-Morales, Cristina-Teresa
    Sierra-Pacho, Magdalena
    Lopez-Corral, Lucia
    Sanchez-Guijo, Fermin
    BIOMEDICINES, 2024, 12 (10)
12345